688075 安旭生物
已收盘 10-08 15:00:00
资讯
新帖
简况
股市必读：安旭生物（688075）9月28日披露最新机构调研信息
证券之星 · 09-29
股市必读：安旭生物（688075）9月28日披露最新机构调研信息
安旭生物新注册《安旭生物全自动干式生化分析嵌入式系统V1.0》等2个项目的软件著作权
证券之星 · 09-15
安旭生物新注册《安旭生物全自动干式生化分析嵌入式系统V1.0》等2个项目的软件著作权
每周股票复盘：安旭生物（688075）拟修订高管薪酬制度
证券之星 · 09-13
每周股票复盘：安旭生物（688075）拟修订高管薪酬制度
安旭生物获得实用新型专利授权：“样本检测装置”
证券之星 · 09-12
安旭生物获得实用新型专利授权：“样本检测装置”
股市必读：安旭生物新发布《安旭生物2026年第一次临时股东会会议资料》
证券之星 · 09-10
股市必读：安旭生物新发布《安旭生物2026年第一次临时股东会会议资料》
安旭生物（688075）披露修订董事及高管薪酬管理制度议案，9月9日股价下跌1.76%
证券之星 · 09-09
安旭生物（688075）披露修订董事及高管薪酬管理制度议案，9月9日股价下跌1.76%
每周股票复盘：安旭生物（688075）累计回购股份707,939股
证券之星 · 09-06
每周股票复盘：安旭生物（688075）累计回购股份707,939股
股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》
证券之星 · 09-03
股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》
安旭生物（688075）披露股份回购进展公告，9月1日股价上涨2.1%
证券之星 · 09-01
安旭生物（688075）披露股份回购进展公告，9月1日股价上涨2.1%
安旭生物：截至8月31日公司累计回购股份707939股
证券日报 · 09-01
安旭生物：截至8月31日公司累计回购股份707939股
安旭生物(688075)6月30日股东户数0.53万户，较上期减少7.39%
证券之星 · 08-28
安旭生物(688075)6月30日股东户数0.53万户，较上期减少7.39%
股市必读：安旭生物新发布《安旭生物关于召开2026年第一次临时股东会的通知》
证券之星 · 08-28
股市必读：安旭生物新发布《安旭生物关于召开2026年第一次临时股东会的通知》
每周股票复盘：安旭生物（688075）累计回购67.19万股
证券之星 · 08-09
每周股票复盘：安旭生物（688075）累计回购67.19万股
股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》
证券之星 · 08-05
股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》
安旭生物（688075）披露股份回购进展公告，8月3日股价上涨0.57%
证券之星 · 08-03
安旭生物（688075）披露股份回购进展公告，8月3日股价上涨0.57%
7月17日安旭生物跌5.00%，广发价值核心混合A基金重仓该股
证券之星 · 07-17
7月17日安旭生物跌5.00%，广发价值核心混合A基金重仓该股
每周股票复盘：安旭生物（688075）回购67万股并调整回购价上限
证券之星 · 07-05
每周股票复盘：安旭生物（688075）回购67万股并调整回购价上限
安旭生物（688075）披露股份回购进展公告，7月2日股价下跌0.03%
证券之星 · 07-02
安旭生物（688075）披露股份回购进展公告，7月2日股价下跌0.03%
每周股票复盘：安旭生物（688075）回购股份532706股
证券之星 · 06-07
每周股票复盘：安旭生物（688075）回购股份532706股
安旭生物（688075）披露股份回购进展公告，6月1日股价上涨1.49%
证券之星 · 06-01
安旭生物（688075）披露股份回购进展公告，6月1日股价上涨1.49%
加载更多
公司概况
公司名称：
杭州安旭生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2021-11-18
主营业务：
杭州安旭生物科技股份有限公司的主营业务是POCT试剂及仪器的研发、生产与销售。公司的主要产品是POCT试剂及仪器。公司为国家级专精特新“小巨人”企业、杭州市企业高新技术研究开发中心、国家高新技术企业、省级高新技术企业研究开发中心，荣获国家知识产权优势企业、浙江省高新技术企业创新能力百强等荣誉称号。
发行价格：
78.28
{"stockData":{"symbol":"688075","market":"SH","secType":"STK","nameCN":"安旭生物","latestPrice":30.64,"timestamp":1791442800000,"preClose":30.96,"halted":0,"volume":1378954,"delay":0,"changeRate":-0.0103,"floatShares":127000000,"shares":127000000,"eps":-0.0042,"marketStatus":"已收盘","change":-0.32,"latestTime":"10-08 15:00:00","open":31.8,"high":31.87,"low":30,"amount":42537600,"amplitude":0.0604,"askPrice":30.67,"askSize":5,"bidPrice":30.64,"bidSize":4,"shortable":0,"etf":0,"ttmEps":-0.0042,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":5,"adr":0,"adjPreClose":30.96,"symbolType":"stock_kcb","openAndCloseTimeList":[[1791423000000,1791430200000],[1791435600000,1791442800000]],"highLimit":34.06,"lowLimit":27.86,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":127082805,"isCdr":false,"pbRate":0.78,"roa":"--","roe":"--","epsLYR":0.55,"committee":0.802198,"marketValue":3894000000,"turnoverRate":0.0109,"status":1,"afterMarket":{"amount":0,"volume":0,"close":30.64,"buyVolume":0,"sellVolume":200,"time":1791444837746,"indexStatus":"已收盘 10-08 15:30:00","preClose":30.96},"floatMarketCap":3894000000},"requestUrl":"/m/hq/s/688075","defaultTab":"news","newsList":[{"id":"2671252307","title":"股市必读：安旭生物（688075）9月28日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671252307?lang=zh_cn&edition=full","pubTime":"2026-09-29 02:21","pubTimestamp":1790619669,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，安旭生物报收于29.91元，上涨0.3%，换手率0.43%，成交量5519.0手，成交额1657.21万元。机构调研要点：截至2026年8月31日，公司累计回购股份707,939股，占总股本0.5571%，支付总额25,344,450.67元。交易信息汇总资金流向9月28日主力资金净流出81.69万元，占总成交额4.93%；游资资金净流出165.1万元，占总成交额9.96%；散户资金净流入246.79万元，占总成交额14.89%。体外诊断试剂以及诊断仪器研发生产项目投资总额5.08亿元，截至6月末投资进度55.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900002154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667698989","title":"安旭生物新注册《安旭生物全自动干式生化分析嵌入式系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2667698989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667698989?lang=zh_cn&edition=full","pubTime":"2026-09-15 02:20","pubTimestamp":1789410024,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安旭生物新注册了2个项目的软件著作权，包括《安旭生物全自动干式生化分析嵌入式系统V1.0》、《KinCare Hub APP0.2.13》等。今年以来安旭生物新注册软件著作权4个，较去年同期减少了60%。通过天眼查大数据分析，杭州安旭生物科技股份有限公司共对外投资了18家企业，参与招投标项目143次；财产线索方面有商标信息76条，专利信息309条，著作权信息59条；此外企业还拥有行政许可117个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500000648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159180","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667857688","title":"每周股票复盘：安旭生物（688075）拟修订高管薪酬制度","url":"https://stock-news.laohu8.com/highlight/detail?id=2667857688","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667857688?lang=zh_cn&edition=full","pubTime":"2026-09-13 04:02","pubTimestamp":1789243339,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，安旭生物报收于28.13元，较上周的29.3元下跌3.99%。本周，安旭生物9月8日盘中最高价报30.23元。安旭生物当前最新总市值35.75亿元，在医疗器械板块市值排名85/129，在两市A股市值排名3933/5218。本周关注点公司公告汇总：安旭生物拟修订高管薪酬制度，强调向关键岗位和一线人才倾斜。公司公告汇总杭州安旭生物科技股份有限公司将召开2026年第一次临时股东会，审议《关于修订<董事和高级管理人员薪酬管理制度>的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666790885","title":"安旭生物获得实用新型专利授权：“样本检测装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666790885","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666790885?lang=zh_cn&edition=full","pubTime":"2026-09-12 03:42","pubTimestamp":1789155779,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示安旭生物新获得一项实用新型专利授权，专利名为“样本检测装置”，专利申请号为CN202521799513.3，授权日为2026年9月11日。本实用新型提供的样本检测装置结构简单，使用者使用时操作更加方便，可提高用户体验和检测效率。今年以来安旭生物新获得专利授权79个，较去年同期增加了107.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091200003144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666532500","title":"股市必读：安旭生物新发布《安旭生物2026年第一次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666532500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666532500?lang=zh_cn&edition=full","pubTime":"2026-09-10 01:41","pubTimestamp":1788975671,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘，安旭生物报收于29.57元，下跌1.76%，换手率0.35%，成交量4429.0手，成交额1312.67万元。公司公告汇总安旭生物2026年第一次临时股东会会议资料杭州安旭生物科技股份有限公司召开2026年第一次临时股东会，审议《关于修订〈董事和高级管理人员薪酬管理制度〉的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000002110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666158116","title":"安旭生物（688075）披露修订董事及高管薪酬管理制度议案，9月9日股价下跌1.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666158116","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666158116?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:43","pubTimestamp":1788947023,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘，安旭生物报收于29.57元，较前一交易日下跌1.76%，最新总市值为37.58亿元。该股当日开盘30.01元，最高30.08元，最低29.42元，成交额达1312.67万元，换手率为0.35%。公司于近日披露《2026年第一次临时股东会会议资料》，拟审议《关于修订<董事和高级管理人员薪酬管理制度>的议案》。制度其余条款不变。现场会议定于2026年9月16日在杭州举行，会议采取现场与网络投票相结合方式。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900030365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366357","title":"每周股票复盘：安旭生物（688075）累计回购股份707,939股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366357","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366357?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:09","pubTimestamp":1788635352,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，安旭生物报收于29.3元，较上周的29.52元下跌0.75%。本周，安旭生物9月2日盘中最高价报29.86元。8月31日盘中最低价报28.92元。安旭生物当前最新总市值37.24亿元，在医疗器械板块市值排名86/129，在两市A股市值排名3894/5214。本周关注点公司公告汇总：安旭生物累计回购股份707,939股，占总股本的0.5571%，已支付资金总额2534.45万元。公司公告汇总安旭生物于2026年4月1日启动股份回购，拟回购金额为2,500万元至4,900万元，价格不超过40.2元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664457438","title":"股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664457438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664457438?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:27","pubTimestamp":1788373630,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，安旭生物报收于29.25元，下跌1.52%，换手率0.29%，成交量3656.0手，成交额1072.98万元。当日关注点交易信息汇总：9月2日主力资金净流出212.08万元，占总成交额19.77%。公司公告汇总：截至2026年8月31日，安旭生物累计回购股份707,939股，占总股本0.5571%，已支付资金总额2534.45万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664505578","title":"安旭生物（688075）披露股份回购进展公告，9月1日股价上涨2.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664505578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664505578?lang=zh_cn&edition=full","pubTime":"2026-09-01 23:09","pubTimestamp":1788275355,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，安旭生物报收于29.7元，较前一交易日上涨2.1%，最新总市值为37.74亿元。该股当日开盘29.14元，最高29.82元，最低28.96元，成交额达1856.54万元，换手率为0.49%。近日，安旭生物发布《关于股份回购进展公告》。截至2026年8月31日，公司累计回购股份707,939股，占总股本的0.5571%，已支付资金总额2534.45万元，回购价格区间为27.95元/股至38.87元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664399857","title":"安旭生物：截至8月31日公司累计回购股份707939股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664399857","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664399857?lang=zh_cn&edition=full","pubTime":"2026-09-01 21:47","pubTimestamp":1788270420,"startTime":"0","endTime":"0","summary":"9月1日，安旭生物发布公告称，截至2026年8月31日，公司通过股份回购专用证券账户，以集中竞价交易方式累计回购股份707，939股，占公司总股本127，082，805股的比例为0.5571%，回购成交的最高价为38.87元/股，最低价为27.95元/股，支付的资金总额为人民币25，344，450.67元（不含印花税、交易佣金等交易费用）。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-01/doc-iniqitrq4831808.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-01/doc-iniqitrq4831808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662352066","title":"安旭生物(688075)6月30日股东户数0.53万户，较上期减少7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662352066","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662352066?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:40","pubTimestamp":1787910047,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安旭生物披露，截至2026年6月30日公司股东户数为5335.0户，较3月31日减少426.0户，减幅为7.39%。在医疗器械行业个股中，安旭生物股东户数低于行业平均水平，截至6月30日，医疗器械行业平均股东户数为2.12万户。从股价来看，2026年3月31日至2026年6月30日，安旭生物区间跌幅为20.06%，在此期间股东户数减少426.0户，减幅为7.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800040692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662341450","title":"股市必读：安旭生物新发布《安旭生物关于召开2026年第一次临时股东会的通知》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662341450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662341450?lang=zh_cn&edition=full","pubTime":"2026-08-28 08:16","pubTimestamp":1787876193,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，安旭生物报收于29.48元，下跌0.71%，换手率0.32%，成交量4095.0手，成交额1206.41万元。公司公告汇总安旭生物关于公司2026年度提质增效重回报专项行动方案的半年度评估报告2026年上半年新增授权专利55项，累计授权专利435项；新增国际认证214项，累计达2117项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800015325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658753376","title":"每周股票复盘：安旭生物（688075）累计回购67.19万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658753376","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658753376?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:31","pubTimestamp":1786213870,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，安旭生物报收于28.94元，较上周的27.92元上涨3.65%。本周，安旭生物8月7日盘中最高价报28.99元。8月3日盘中最低价报27.79元。安旭生物当前最新总市值36.78亿元，在医疗器械板块市值排名90/129，在两市A股市值排名3831/5205。本次回购用于员工持股计划或股权激励，回购期限为2026年4月1日至2027年3月29日，资金总额预计为2,500万元至4,900万元。回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657305565","title":"股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657305565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657305565?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:37","pubTimestamp":1785868629,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，安旭生物报收于28.32元，上涨0.85%，换手率0.81%，成交量1.02万手，成交额2887.89万元。公司公告汇总：截至2026年7月31日，安旭生物累计回购股份671,939股，占总股本0.5287%，已支付资金总额24,323,862.59元，回购价格区间为30.48元/股至38.87元/股。本次回购用于员工持股计划或股权激励，回购期限为2026年4月1日至2027年3月29日，资金总额预计为2,500万元至4,900万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656776913","title":"安旭生物（688075）披露股份回购进展公告，8月3日股价上涨0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656776913","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656776913?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:20","pubTimestamp":1785766824,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，安旭生物报收于28.08元，较前一交易日上涨0.57%，最新总市值为35.68亿元。近日，安旭生物发布《关于股份回购进展公告》。本次回购用于员工持股计划或股权激励，回购期限为2026年4月1日至2027年3月29日，资金总额预计为2,500万元至4,900万元。回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652548405","title":"7月17日安旭生物跌5.00%，广发价值核心混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652548405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652548405?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:20","pubTimestamp":1784276449,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日安旭生物跌5.00%，收盘报29.06元，换手率0.78%，成交量9931.0手，成交额2944.58万元。重仓安旭生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为广发基金的广发价值核心混合A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700029675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649692240","title":"每周股票复盘：安旭生物（688075）回购67万股并调整回购价上限","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649692240?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:25","pubTimestamp":1783196712,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，安旭生物报收于31.11元，较上周的30.45元上涨2.17%。本周，安旭生物6月29日盘中最高价报31.49元。本周关注点公司公告汇总：安旭生物已累计回购671,939股，支付资金24,323,862.59元。公司公告汇总：因权益分派实施，安旭生物回购股份价格上限由41元/股调整为40.2元/股。安旭生物2025年年度权益分派实施公告：本次利润分配每股派发现金红利0.8元（含税），股权登记日为2026年7月8日，除权（息）日与现金红利发放日均为2026年7月9日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648506908","title":"安旭生物（688075）披露股份回购进展公告，7月2日股价下跌0.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648506908","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648506908?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:48","pubTimestamp":1782985713,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，安旭生物报收于30.37元，较前一交易日下跌0.03%，最新总市值为38.6亿元。该股当日开盘30.38元，最高30.89元，最低30.01元，成交额达2115.82万元，换手率为0.55%。安旭生物于2026年7月2日发布《关于股份回购进展公告》。公告显示，公司于2026年3月30日召开董事会，审议通过以集中竞价交易方式回购股份的方案，拟用于员工持股计划或股权激励。本次回购进展符合相关规定及公司方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200030559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641127221","title":"每周股票复盘：安旭生物（688075）回购股份532706股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641127221?lang=zh_cn&edition=full","pubTime":"2026-06-07 03:03","pubTimestamp":1780772592,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，安旭生物报收于32.9元，较上周的34.24元下跌3.91%。本周，安旭生物6月1日盘中最高价报35.14元。本周关注点公司公告汇总：安旭生物已回购股份532,706股，占总股本0.4192%。公司公告汇总安旭生物关于股份回购进展公告：杭州安旭生物科技股份有限公司自2026年4月1日启动股份回购方案，截至2026年5月31日，累计通过集中竞价交易方式回购股份532,706股，占公司总股本的0.4192%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700001000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640381953","title":"安旭生物（688075）披露股份回购进展公告，6月1日股价上涨1.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640381953","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640381953?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:22","pubTimestamp":1780309339,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，安旭生物报收于34.75元，较前一交易日上涨1.49%，最新总市值为44.16亿元。近日，安旭生物发布《关于股份回购进展公告》。公告显示，公司自2026年4月1日启动股份回购方案，截至2026年5月31日，已通过集中竞价交易方式累计回购股份532,706股，占公司总股本的0.4192%。回购股份的最高价为38.87元/股，最低价为34.74元/股，支付资金总额为19,886,859.55元。回购股份拟用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100029948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791460866779,"stockEarnings":[{"period":"1week","weight":0.0181},{"period":"1month","weight":0.0643},{"period":"3month","weight":0.047},{"period":"6month","weight":-0.1567},{"period":"1year","weight":-0.1827},{"period":"ytd","weight":-0.1777}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州安旭生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"5335人(较上一季度减少7.39%)","perCapita":"23820股","listingDate":"2021-11-18","address":"浙江省杭州市拱墅区莫干山路1418-50号4幢3层(上城科技工业基地)","registeredCapital":"12708万元","survey":" 杭州安旭生物科技股份有限公司的主营业务是POCT试剂及仪器的研发、生产与销售。公司的主要产品是POCT试剂及仪器。公司为国家级专精特新“小巨人”企业、杭州市企业高新技术研究开发中心、国家高新技术企业、省级高新技术企业研究开发中心，荣获国家知识产权优势企业、浙江省高新技术企业创新能力百强等荣誉称号。","listedPrice":78.28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安旭生物,688075,安旭生物股票,安旭生物股票老虎,安旭生物股票老虎国际,安旭生物行情,安旭生物股票行情,安旭生物股价,安旭生物股市,安旭生物股票价格,安旭生物股票交易,安旭生物股票购买,安旭生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}